Category
Bortezomib
CAS Number
NA
Molecular Formula
C19H25BN4O4
Molecular Weight
384.3 g/mol
Synonym

(1-((S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanamido)pentyl)boronic acid; 1-[[(2S)-1-Oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]pentyl boronic Acid

Keywords
Fine Chemicals
Pharmaceutical Standards
Intermediates
Chiral standards
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib Impurity C is a recognized impurity or degradation product of Bortezomib. Like other impurities, it forms during synthesis or storage and has a chemical structure slightly different from the active drug. Its presence is monitored and controlled because it can affect the drug’s potency, stability, or safety in pharmaceutical formulations.